List of Figures
Figure 1: Dermatology Drugs Market, 7MM, Epidemiology Patterns for Atopic Dermatitis, 2017–2024 21
Figure 2: Dermatology Drugs Market, 7MM, Epidemiology Patterns for Acne Vulgaris, 2017–2024 22
Figure 3: Dermatology Drugs Market, 7MM, Epidemiology Patterns for Psoriasis, 2017–2024 23
Figure 4: Dermatology Drugs Market, Global, Key Marketed Products and Approved Indications, 2018 30
Figure 5: Dermatology Drugs Market, Global, Annual Revenue for Humira ($bn), 2006–2024 32
Figure 6: Dermatology Drugs Market, Global, Annual Revenue for Enbrel ($bn), 2006–2024 34
Figure 7: Dermatology Drugs Market, Global, Annual Revenue for Remicade ($bn), 2006–2024 36
Figure 8: Dermatology Drugs Market, Global, Annual Revenue for Stelara ($bn), 2010–2024 38
Figure 9: Dermatology Drugs Market, Global, Annual Revenue for Cosentyx ($bn), 2015–2024 40
Figure 10: Dermatology Drugs Market, Global, Annual Revenue for Taltz ($bn), 2016–2024 41
Figure 11: Dermatology Drugs Market, Global, Annual Revenue for Dupixent ($bn), 2017–2024 43
Figure 12: Dermatology Drugs Market, Global, Annual Revenue for Eucrisa ($bn), 2016–2024 44
Figure 13: Dermatology Drugs Market, Global, Annual Revenue for Neoral ($m), 2006–2024 46
Figure 14: Dermatology Drugs Market, Global, Annual Revenue for Protopic ($m), 2006–2015 47
Figure 15: Dermatology Drugs Market, Global, Annual Revenue for Elidel ($m), 2006–2024 48
Figure 16: Dermatology Drugs Market, Global, Annual Revenue for Differin ($m), 2008–2015 50
Figure 17: Dermatology Drugs Market, Global, Annual Revenue for Elocon ($m), 2006–2024 51
Figure 18: Dermatology Drugs Market, Global, Annual Revenue for Metolate ($m), 2007–2013 52
Figure 19: Dermatology Drugs Market, Global, Annual Revenue for Aczone ($m), 2015–2024 54
Figure 20: Dermatology Drugs Market, Global, Annual Revenue for Retin-A ($m), 2014–2024 56
Figure 21: Dermatology Drugs Market, Global, Annual Revenue for Episalvan ($m), 2020–2024 58
Figure 22: Dermatology Drugs Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2018 59
Figure 23: Dermatology Drugs Market, Global, Pipeline for Dermatology by Stage of Development, Molecule Type and Program Type, 2018 61
Figure 24: Dermatology Drugs Market, Global, Pipeline for Key Dermatology Indications by Stage of Development, 2018 62
Figure 25: Dermatology Drugs Market, Global, Pipeline for Key Dermatology Indications by Molecule Type, 2018 63
Figure 26: Dermatology Drugs Market, Global, Pipeline for Dermatology by Molecular Target Class, 2018 65
Figure 27: Dermatology Drugs Market, Global, Pipeline for Key Dermatology Indications by Molecular Target Class, 2018 66
Figure 28: Dermatology Drugs Market, Global, Clinical Trial Failure Rates by Stage of Development and Overall Clinical Trial Attrition Rate (%), 2006–2018 67
Figure 29: Dermatology Drugs Market, Global, Clinical Trial Failure Rates by Key Indication and Stage of Development (%), 2006–2018 68
Figure 30: Dermatology Drugs Market, Global, Clinical Trial Failure Rates by Molecule Type and Stage of Development (%), 2006–2018 69
Figure 31: Dermatology Drugs Market, Global, Clinical Trial Failure Rates by Molecular Target Class and Stage of Development (%), 2006–2018 70
Figure 32: Dermatology Drugs Market, Global, Clinical Trial Duration by Stage of Development (months), 2006–2018 70
Figure 33: Dermatology Drugs Market, Global, Clinical Trial Duration by Key Indication and Stage of Development (months), 2006–2018 71
Figure 34: Dermatology Drugs Market, Global, Clinical Trial Duration by Molecule Type and Stage of Development (months), 2006–2018 72
Figure 35: Dermatology Drugs Market, Global, Clinical Trial Duration by Molecular Target Class and Stage of Development (months), 2006–2018 73
Figure 36: Dermatology Drugs Market, Global, Clinical Trial Size by Stage of Development (participants), 2006–2018 73
Figure 37: Dermatology Drugs Market, Global, Clinical Trial Size by Key Indication and Stage of Development (participants), 2006–2018 74
Figure 38: Dermatology Drugs Market, Global, Clinical Trial Size by Molecule Type and Stage of Development (participants), 2006–2018 75
Figure 39: Dermatology Drugs Market, Global, Clinical Trial Size by Molecular Target Class and Stage of Development (participants), 2006–2018 76
Figure 40: Dermatology Drugs Market, Global, Clinical Program Size by Stage of Development (participants), 2006–2018 77
Figure 41: Dermatology Drugs Market, Global, Clinical Program Size by Key Indication and Stage of Development (participants), 2006–2018 78
Figure 42: Dermatology Drugs Market, Global, Clinical Program Size by Molecule Type and Stage of Development (participants), 2006–2018 79
Figure 43: Dermatology Drugs Market, Global, Clinical Program Size by Molecular Target Class and Stage of Development (participants), 2006–2018 80
Figure 44: Dermatology Drugs Market, Global, Revenue Forecast for Risankizumab ($bn), 2019–2024 81
Figure 45: Dermatology Drugs Market, Global, Revenue Forecast for MOR106 ($m), 2023–2024 82
Figure 46: Dermatology Drugs Market, Global, Revenue Forecast for ANB-019 ($m), 2020–2024 83
Figure 47: Dermatology Drugs Market, Global, Revenue Forecast for Lebrikizumab ($m), 2021–2024 84
Figure 48: Dermatology Drugs Market, Global, Revenue Forecast for FMX-101 ($m), 2019–2024 85
Figure 49: Dermatology Drugs Market, Global, Market Size ($bn), 2017–2024 86
Figure 50: Dermatology Drugs Market, Global, Annual Revenue Forecast for Premium and Generic Products ($bn), 2017–2024 88
Figure 51: Dermatology Drugs Market, Global, Annual Revenue Forecast for TNF-a inhibitors ($bn), 2017–2024 91
Figure 52: Dermatology Drugs Market, Global, Annual Revenue Forecast for IL-17 inhibitors ($bn), 2017–2024 92
Figure 53: Dermatology Drugs Market, Global, Annual Revenue Forecast for IL-23 inhibitors ($bn), 2017–2024 93
Figure 54: Dermatology Drugs Market, Global, Annual Revenue Forecast for IL-1, 4, 12, 13 and 33 inhibitors ($bn), 2017–2024 94
Figure 55: Dermatology Drugs Market, Global, Annual Revenue Forecast for PDE4 inhibitors ($bn), 2017–2024 95
Figure 56: Dermatology Drugs Market, Global, Annual Revenue Forecast for Glucocorticoids ($bn), 2017–2024 96
Figure 57: Dermatology Drugs Market, Global, Annual Revenue Forecast for JAK inhibitors ($bn), 2019–2024 97
Figure 58: Dermatology Drugs Market, Global, Company Analysis Matrix, 2017–2024 98
Figure 59: Dermatology Drugs Market, Global, Cluster by CAGR and Market Share, 2017–2024 99
Figure 60: Dermatology Drugs Market, Global, Market Share by Company (%), 2017–2024 105
Figure 61: Dermatology Drugs Market, Global, Companies by Compound Annual Growth Rate (%), 2017–2024 107
Figure 62: Dermatology Drugs Market, Global, Revenues by Route of Acquisition, 2017–2024 108
Figure 63: Dermatology Drugs Market, Global, AbbVie Annual Revenue Forecast ($bn), 2017–2024 109
Figure 64: Dermatology Drugs Market, Global, Novartis, Annual Revenue Forecast ($bn), 2017–2024 110
Figure 65: Dermatology Drugs Market, Global, Johnson & Johnson Annual Revenue Forecast ($bn), 2017–2024 111
Figure 66: Dermatology Drugs Market, Global, Sanofi, Annual Revenue Forecast ($bn), 2017–2024 112
Figure 67: Dermatology Drugs Market, Global, Pfizer Annual Revenue Forecast ($bn), 2017–2024 114
Figure 68: Dermatology Drugs Market, Global, Eli Lilly Annual Revenue Forecast ($bn), 2017–2024 115
Figure 69: Dermatology Drugs Market, Global, High-Activity and Late-Stage Pipeline Developers by Company Type, 2018 116
Figure 70: Dermatology Drugs Market, Global, Overall, High-Activity and Late-Stage Pipeline Developers by Level of Dermatology Specialization, 2018 117
Figure 71: Dermatology Drugs Market, Global, Proportion of Total Company Revenue Attributed to Dermatology, 2017–2024 118
Figure 72: Dermatology Drugs Market, Global, Licensing Deals by Region, Deal Value and Year, 2006–2018 120
Figure 73: Dermatology Drugs Market, Global, Licensing Deals by Key Indication, 2006–2018 121
Figure 74: Dermatology Drugs Market, Global, Licensing Deals by Stage of Development and Value, 2006–2018 122
Figure 75: Dermatology Drugs Market, Global, Licensing Deals by Molecule Type and Molecular Target, 2006–2018 123
Figure 76: Dermatology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 1) 124
Figure 77: Dermatology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 2) 125
Figure 78: Dermatology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 3) 126
Figure 79: Dermatology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 4) 127
Figure 80: Dermatology Drugs Market, Global, Co-development Deals by Region, Year and Value, 2006–2018 128
Figure 81: Dermatology Drugs Market, Global, Co-development Deals by Indication, 2006–2018 129
Figure 82: Dermatology Drugs Market, Global, Co-development Deals by Stage of Development and Value, 2006–2018 129
Figure 83: Dermatology Drugs Market, Global, Co-development Deals by Molecule Type and Molecular Target, 2006–2018 130
Figure 84: Dermatology Drugs Market, Global, Co-development Deals with Disclosed Values, 2006–2018 (part 1) 131
Figure 85: Dermatology Drugs Market, Global, Co-development Deals with Disclosed Values, 2006–2018 (part 2) 132
Figure 86: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 1 140
Figure 87: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 2 141
Figure 88: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 3 142
Figure 89: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 4 143
Figure 90: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 5 144
Figure 91: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 6 145
Figure 92: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 7 146
Figure 93: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 8 147
Figure 94: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 9 148
Figure 95: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 10 149
Figure 96: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 11 150
Figure 97: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018 Part 12 151
Figure 98: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 13 152
Figure 99: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 14 153
Figure 100: Dermatology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 15 154